Autopsy report · NCT05200403
Improvement In Scratch Behavior And Sleep In Patients With Atopic Dermatitis
Cause of deathFunding or business
“Funding was stoppped by grantor.”
Life of this trial
- Registered 7 months before it started.
- Ran for about 1 year 7 months before it stopped.
- 72 participants enrolled.
- Results were posted on the registry 1 year 1 month after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 4
- Sponsor
- Boston University
- Sponsor type
- University, hospital or other
- Conditions
- Atopic Dermatitis
- Interventions
- Crisaborole 2%; Vehicle treatment; Accelerometry device for children; Accelerometry device for adult caregivers
- Participants
- 72
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Clinical, Pharmacological and Molecular Effects of IV and Oral Acetaminophen in Adults With aSAH
“Funding was stopped” - Effectiveness of the Rapid Intravascular Start (RIVS) System Versus Conventional Catheter
“Funding Stopped” - HCV Test and Treat Utilizing Simplified HCV Patient Education
“The funding was halted.” - A Study of APR-246 in Oesophageal Cancer
“Funding ceased” - Observational Study of the Effect of Ozanimod on Fatigue in Multiple Sclerosis Patients
“Funding ended prematurely”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.